Agile Therapeutics Inc (AGRX)
0.40
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Agile Therapeutics Gross Profit Margin (Quarterly): 39.37% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.37% |
| September 30, 2023 | 62.82% |
| June 30, 2023 | 58.08% |
| March 31, 2023 | 47.47% |
| December 31, 2022 | 58.63% |
| September 30, 2022 | 52.53% |
| June 30, 2022 | -4.94% |
| Date | Value |
|---|---|
| March 31, 2022 | 13.29% |
| December 31, 2021 | -276.6% |
| September 30, 2021 | -110.6% |
| June 30, 2021 | 3.38% |
| March 31, 2021 | -900.9% |
| December 31, 2020 | 62.35% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-900.9%
Minimum
Mar 2021
62.82%
Maximum
Sep 2023
-68.85%
Average
39.37%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| Altimmune Inc | -- |
| iBio Inc | -- |
| Verastem Inc | -- |
| Oragenics Inc | -- |
| Actinium Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -117.3% |
| Profit Margin (Quarterly) | -123.7% |
| Operating Margin (Quarterly) | -112.1% |
| Return on Net Operating Assets | -202.1% |